uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted May 01, 2024

FDA Warns Consumers Not to Use Ossos-Sans Supplement for Joints

On April 17, 2024, the FDA warned consumers not to purchase or use Ossos-Sans, a supplement promoted to treat osteoarthritis, osteoporosis, and other conditions, because it contains undeclared drugs, including diclofenac and methocarbamol.

Diclofenac is a prescription non-steroidal anti-inflammatory drug (NSAID) that can cause serious cardiovascular events such as heart attack or stroke, as well as bleeding, ulceration, and fatal tears of the stomach and intestines, or liver toxicity. Methocarbamol is a prescription muscle relaxant that can cause dizziness, low blood pressure and sedation. These drugs imay also interact with other medications and significantly increase the risk of adverse events.

Ossos-Sans (see product photo) is labeled as containing glucosamine, chondroitin, vitamin D, magnesium, curcumin, and other ingredients marketed to reduce joint pain or have other joint and bone health benefits. It was sold on various websites, including, and possibly in retail stores.

Consumers and healthcare providers can report any adverse reactions to the FDA’s MedWatch Voluntary Reporting Program.

For more information about related products, see ConsumerLab’s Reviews of Joint Health Supplements and Turmeric and Curcumin Supplements and Spices.

Also see:

Which supplements help with arthritis?

For more information, use the link below.

Ossos-Sans contains hidden drug ingredients

See related recalls and warnings:

Drug Found in Umary Supplement

Pain Relief Tea Recalled, Found to Contain Prescription Drugs

Joint Pain Supplements Recalled Due to Undeclared Drug Ingredients

FDA Warns Consumers Not to Use Tapee Tea

Toxic Herb Found In Weight Supplements